CL2012003125A1 - Metodo para eliminar microbios de las manos que comprende una composicion farmaceutica que comprende povidona yodada, una amida terciaria, aceite de coco, al menos un tensioactivo y agua; composicion farmaceutica. - Google Patents

Metodo para eliminar microbios de las manos que comprende una composicion farmaceutica que comprende povidona yodada, una amida terciaria, aceite de coco, al menos un tensioactivo y agua; composicion farmaceutica.

Info

Publication number
CL2012003125A1
CL2012003125A1 CL2012003125A CL2012003125A CL2012003125A1 CL 2012003125 A1 CL2012003125 A1 CL 2012003125A1 CL 2012003125 A CL2012003125 A CL 2012003125A CL 2012003125 A CL2012003125 A CL 2012003125A CL 2012003125 A1 CL2012003125 A1 CL 2012003125A1
Authority
CL
Chile
Prior art keywords
pharmaceutical composition
hands
surfactant
water
coconut oil
Prior art date
Application number
CL2012003125A
Other languages
English (en)
Inventor
Griscom Bettle Iii
Original Assignee
Microdermis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microdermis Corp filed Critical Microdermis Corp
Publication of CL2012003125A1 publication Critical patent/CL2012003125A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Insects & Arthropods (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Método para eliminar microbios de las manos que comprende una composición farmacéutica que comprende povidona yodada, una amida terciaria, aceite de coco, al menos un tensioactivo y agua; composición farmacéutica.
CL2012003125A 2010-05-07 2012-11-07 Metodo para eliminar microbios de las manos que comprende una composicion farmaceutica que comprende povidona yodada, una amida terciaria, aceite de coco, al menos un tensioactivo y agua; composicion farmaceutica. CL2012003125A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33241710P 2010-05-07 2010-05-07

Publications (1)

Publication Number Publication Date
CL2012003125A1 true CL2012003125A1 (es) 2013-07-12

Family

ID=44904474

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003125A CL2012003125A1 (es) 2010-05-07 2012-11-07 Metodo para eliminar microbios de las manos que comprende una composicion farmaceutica que comprende povidona yodada, una amida terciaria, aceite de coco, al menos un tensioactivo y agua; composicion farmaceutica.

Country Status (6)

Country Link
US (3) US9393283B2 (es)
EP (2) EP3146972A1 (es)
BR (1) BR112012028451A2 (es)
CL (1) CL2012003125A1 (es)
CO (1) CO6640220A2 (es)
WO (1) WO2011140310A2 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
CA2794171C (en) 2010-03-24 2018-07-03 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US20130121953A1 (en) * 2011-10-31 2013-05-16 Microdermis Corporation Compositions
US20180110804A1 (en) * 2015-02-04 2018-04-26 Nugene, Inc. Burn, scar, and wound treatment creams
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12186296B1 (en) 2016-07-22 2025-01-07 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
UY37341A (es) 2016-07-22 2017-11-30 Flamel Ireland Ltd Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada
US12478604B1 (en) 2016-07-22 2025-11-25 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US20180263936A1 (en) 2017-03-17 2018-09-20 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
CN108186567B (zh) * 2018-02-11 2020-03-20 中山市天图精细化工有限公司 一种个人护理用碘伏清洁消毒气雾剂及其制备方法
CA3115122A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
EP3930702A1 (en) 2019-03-01 2022-01-05 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
TW202139986A (zh) 2020-02-21 2021-11-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 治療原發性嗜睡症之方法
WO2022076824A1 (en) 2020-10-08 2022-04-14 Jazz Pharmaceuticals Ireland Limited Sodium oxybate to treat idiopathic hypersomnia
AU2022277569A1 (en) * 2021-05-18 2023-12-14 Povinez Llc Nasal antiseptic
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
JP2026513019A (ja) 2023-02-03 2026-04-22 トリス・フアルマ・インコーポレーテツド １晩１回の低ナトリウムオキシベート組成物
WO2025243071A1 (en) 2024-05-22 2025-11-27 Apex Laboratories Private Limited A medicinal composition of povidone iodine and a biopolymer and a process of making it

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839080A (en) * 1987-04-30 1989-06-13 Neutrogena Corporation Antibacterial iodophor soap base composition and method of making same
US5607699A (en) * 1995-05-12 1997-03-04 Becton Dickinson And Company Non-aqueous emiollient iodophor formulations
US5716611A (en) * 1996-01-02 1998-02-10 Euro-Celtique, S.A. Emollient antimicrobial formulations containing povidone iodine
DE69705968T2 (de) * 1997-02-14 2002-04-18 De Meeus D'argenteuil, Reginald Zubereitung auf der basis von kokosöl und ihre verwendung
JP4035258B2 (ja) 1999-05-10 2008-01-16 花王株式会社 皮膚外用剤
US6583184B1 (en) 2000-11-27 2003-06-24 Avon Products, Inc. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
AU2003299034A1 (en) 2002-09-20 2004-04-08 Griscom Bettle Iii Transdermal compositions
US7067562B2 (en) 2002-12-20 2006-06-27 Conocophillips Company Iron-based Fischer-Tropsch catalysts and methods of making and using
BRPI0608690B8 (pt) * 2005-03-10 2021-05-25 3M Innovative Properties Co uso de uma composição antimicrobiana
US9011943B2 (en) * 2007-02-16 2015-04-21 Skin Evolution LLC Compositions and methods for alleviating skin disorders

Also Published As

Publication number Publication date
WO2011140310A2 (en) 2011-11-10
US20170157258A1 (en) 2017-06-08
US9393283B2 (en) 2016-07-19
CO6640220A2 (es) 2013-03-22
EP3146972A1 (en) 2017-03-29
EP2566488A2 (en) 2013-03-13
EP2566488B1 (en) 2016-07-13
US20200276315A1 (en) 2020-09-03
BR112012028451A2 (pt) 2016-07-19
US20140093583A1 (en) 2014-04-03
WO2011140310A3 (en) 2012-04-05
EP2566488A4 (en) 2013-11-13

Similar Documents

Publication Publication Date Title
CL2012003125A1 (es) Metodo para eliminar microbios de las manos que comprende una composicion farmaceutica que comprende povidona yodada, una amida terciaria, aceite de coco, al menos un tensioactivo y agua; composicion farmaceutica.
BR112015028853A2 (pt) Composição detergente com ph baixo
FR2918702B1 (fr) Clinquant pour aube de turbomachine
DK2719388T3 (da) Borholdige små molekyler som antiinflammatoriske midler
JP2013116291A5 (es)
CL2013002874A1 (es) Metodo para tratar condiciones asociadas con la activacion del complemento dependiente de serino proteasa 2 asociada a la lactina de union a membrana (masp-2) mediante un agente inhibidor de masp-2, preferentemente u anticuerpo anti-(masp-2).
MX382899B (es) Composiciones y métodos que comprenden variantes de proteasa termolisina.
MX371497B (es) Composiciones y metodos que comprenden una variante de enzima lipolitica.
DK2970283T3 (da) Substituerede 2-aza-bicyclo[2.2.1]heptan-3-carboxylsyre-(benzyl-cyano-methyl)-amider som inhibitorer af cathepsin-c
CL2007001674A1 (es) Compuestos derivados de heterociclos, inhibidores de aspartil proteasa; composicion farmaceutica que los comprende;y su uso para tratar enfermedades cardiovasculares,cognitivas y neurodegenerativas.
DK2003120T3 (da) Azapeptidderivater som HIV-proteaseinhibitorer
PT1938647T (pt) Técnica para execução de um procedimento de acesso aleatório através de uma interface rádio
DK2032535T3 (da) Spiro-cycliske nitriler som protease-inhibitorer
ECSP13013094A (es) Composiciones de limpieza de sal colina
ATE538092T1 (de) Asparaginsäureproteaseinhibitoren
DOP2013000293A (es) Composiciones líquidas de limpieza de sal
CL2015002837A1 (es) Compuestos de piridinilpirazoloquinolina.
CL2016001095A1 (es) Silicato de zirconio microporoso para el tratamiento de hipercalemia.
CL2013002903A1 (es) Composicion que comprende azadiractina; metodo para el tratamiento anti-macroincrustacion de al menos un polimeros; y su uso.
UY35228A (es) Composiciones acuosas de cloquintocet-mexilo de temperatura estable
AR093738A1 (es) Formas solidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos
BR112014014724A2 (pt) composição líquida detergente, método de branquear por ar uma superfície e uso da combinação
FR2980955B1 (fr) Compositions desinfectantes et detergentes.
ECSP13012459A (es) Valsartan altamente cristalino
DE602006006418D1 (de) Hiv-protease-inhibitoren